Veradigm (NASDAQ:MDRX) Shares Gap Down - Should You Sell?

Market Beat
2025.11.11 19:34
portai
I'm PortAI, I can summarize articles.

Veradigm Inc. (NASDAQ:MDRX) shares gapped down from $4.80 to $4.15 before opening, last trading at $4.99. The company has a market cap of $522.72 million, a P/E ratio of 24.00, and a beta of 0.77. Analysts currently rate Veradigm as a Hold, but suggest five other stocks as better investment options. Veradigm provides healthcare IT solutions, including electronic health records and analytics.

Veradigm Inc. (NASDAQ:MDRX - Get Free Report)'s stock price gapped down before the market opened on Monday . The stock had previously closed at $4.80, but opened at $4.15. Veradigm shares last traded at $4.99, with a volume of 356 shares changing hands.

Veradigm Stock Performance

The firm's 50-day simple moving average is $4.73 and its 200-day simple moving average is $4.62. The company has a market capitalization of $522.72 million, a price-to-earnings ratio of 24.00 and a beta of 0.77.

Veradigm Company Profile

(Get Free Report)

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

See Also

  • Five stocks we like better than Veradigm
  • Most active stocks: Dollar volume vs share volume
  • Monday.com Opens Generational Opportunity With Manic Sell-Off
  • Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
  • An Earnings Win With a Stock Slump: What's Happening With D-Wave?
  • How to Calculate Inflation Rate
  • 3 Stocks Showing Relative Strength as Markets Pull Back

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Veradigm Right Now?

Before you consider Veradigm, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veradigm wasn't on the list.

While Veradigm currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Source: Market Beat The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer